RecruitingNot Applicable

Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")

France200 participantsStarted 2022-10-01

Plain-language summary

Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with juvenile PRR (disease onset before age 18) * Followed in the : * The MALO CRMR * One of the MALO network's CCMRs * One of the main correspondent centers Exclusion Criteria: * Patients objecting to the collection of their personal data * Parents of minor patients objecting to the collection of their child's personal data

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Epidemiology of juvenile RRP in France by clinical information

Timeframe: 10 years

Epidemiology of juvenile PRR in France according to vaccine and adjuvant therapeutic information

Timeframe: 10 years

Epidemiology of juvenile PRR in France by paraclinical information

Timeframe: 10 years

Trial details

NCT IDNCT06000527

SponsorImagine Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2032-09-30

Contact for this trial

Nicolas LEBOULANGER, MD

0144494682 nicolas.leboulanger@aphp.fr

View on ClinicalTrials.gov More Juvenile Recurrent Respiratory Papillomatosis trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.